Skip to content

BillionToOne, Inc. BLLN Contract Liabilities

Contract Liabilities at other companies

Natera, Inc. logo
Natera, Inc.NTRA
$17M
Arcus Biosciences logo
Arcus BiosciencesRCUS
$79M-72.9%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$807K-96.7%
Illumina logo
IlluminaILMN
Guardant Health logo
Guardant HealthGH
Agilent Technologies logo
Agilent TechnologiesA

Other financials

Income statement

See full
Revenue$108.4M+83.8%
Gross profit$79.1M+108%
Operating income$17.8M+870%
Net income$18.0M+551%
EPS (diluted)$0.34+187%

Balance sheet

See full
Cash & equivalents$537.5M+181%
Total debt$144.2M
Total equity$505.6M+300%
Total assets$700.7M

Cash flow

See full
Operating cash flow$15.4M+488%
CapEx$4.5M+90.5%
Free cash flow$11.0M+3,842%

Valuation

See full
Market cap$4.8B

Profitability

See full
Gross margin70.4%
Operating margin-96.9%
Net margin8.4%
FCF margin-83.4%

Returns & leverage

See full
Debt / equity0.3×
Current ratio10.9×

Where this comes from

Reported directly by BillionToOne, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: BillionToOne, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BillionToOne, Inc. 's contract liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BillionToOne, Inc. 's contract liabilities?
BillionToOne, Inc. (BLLN) reported contract liabilities of $0 in Q1 2026.
What does contract liabilities mean?
Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.